Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) - Total Liabilities
Based on the latest financial reports, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) has total liabilities worth $8.64 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Oaktree Acquisition Corp. III Life Scien annual equity growth to track the company's year-over-year net asset growth rate.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share - Total Liabilities Trend (2024–2025)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's total liabilities have evolved over time, based on quarterly financial data.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Competitors by Total Liabilities
The table below lists competitors of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Iberpapel Gestion SA
MC:IBG
|
Spain | €56.99 Million |
|
Melon SA
SN:MELON
|
Chile | CL$179.67 Billion |
|
Strike Energy Limited
F:RJN
|
Germany | €130.16 Million |
|
AME Elite Consortium Bhd
KLSE:5293
|
Malaysia | RM1.09 Billion |
|
ThinTech Materials Technology Co Ltd
TWO:3663
|
Taiwan | NT$2.01 Billion |
|
Favite Inc
TW:3535
|
Taiwan | NT$616.49 Million |
|
XINTE ENERGY CO. CL.H YC1
F:9M7
|
Germany | €45.07 Billion |
|
SBC Exports Limited
NSE:SBC
|
India | Rs2.73 Billion |
Liability Composition Analysis (2024–2025)
This chart breaks down Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Oaktree Acquisition Corp. III Life Scien (OACC) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (2024–2025)
The table below shows the annual total liabilities of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share from 2024 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $8.32 Million | +7.39% |
| 2024-12-31 | $7.75 Million | -- |
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more